Though GE Healthcare Revs Grow, Contribution to Corporate Still Slides | GenomeWeb

While GE Healthcare's revenues are skyrocketing, the unit's contribution to GE's overall revenues, which CEO Jeffrey Immelt has promised to grow at 8 percent a year, is not keeping pace.

In the three quarters since it closed the $10-billion acquisition of Amersham and created GE Healthcare to house both the acquisition and the company's legacy medical systems, the unit has averaged 37 percent growth in revenues, and 34 percent growth in profits, year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.